Find clinical trials for Prostate Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near New York, NY, USA:
biopsy alone in diagnosing subjects with clinically significant prostate cancer with MRI visible lesions. This study will consist o...
New York, New York, United States and 2 other locations
and docetaxel in patients with newly metastatic, hormone-sensitive prostate cancer (mHSPC), using a primary endpoint of undetectabl...
Phase 2
New York, New York, United States
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
New York, New York, United States and 8 other locations
study is a randomized study that compares 5 radiation therapy treatments to 2 radiation therapy treatments in men with low or intermediate-risk prostate...
Phase 2
New York, New York, United States and 1 other location
the UroNav software and DynaCAD software for planning and treating prostate cancer as an add on to the already approved workflow of...
New York, New York, United States and 2 other locations
A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate ...
Phase 1, Phase 2
New York, New York, United States and 9 other locations
A Phase 1/2a, open-label, multicenter study of intramuscular (i.m.) PRL-02 depot in participants with advanced prostate cancer....
Phase 1, Phase 2
Morristown, New Jersey, United States and 13 other locations
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
New York, New York, United States and 92 other locations
pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...
Phase 1
New York, New York, United States and 10 other locations
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Pennington, New Jersey, United States and 107 other locations
Clinical trials
Research sites
Resources
Legal